Immunologic and nonimmunologic sclerodermal skin conditions - review

Scleroderma-like cutaneous lesions have been found in many pathological conditions and they have the clinical appearance of sclerotic or scleroatrophic lesions. Affected skin biopsies described histopathological changes similar to those of scleroderma located strictly on the skin or those of systemic sclerosis. These skin lesions can be found in inflammatory diseases with autoimmune substrate (generalized morphea, chronic graft versus host disease, eosinophilic fasciitis), tissue storage diseases (scleredema, scleromyxedema, nephrogenyc systemic fibrosis, systemic amyloidosis), metabolic diseases (porphyrya cutanea tarda, phenylketonuria, hypothyroidism, scleredema diabeticorum), progeroid syndromes. Given the multiple etiologies of sclerodermal lesions, a correct differential diagnosis is necessary to establish the appropriate treatment.

[1]  G. Nuovo,et al.  Lichen sclerosus: A C5B-9 mediated chronic microvascular injury syndrome potentially reflective of common adult comorbidities. , 2022, Annals of diagnostic pathology.

[2]  A. Tatu,et al.  Interrelationship and Sequencing of Interleukins4, 13, 31, and 33 – An Integrated Systematic Review: Dermatological and Multidisciplinary Perspectives , 2022, Journal of inflammation research.

[3]  A. Tatu,et al.  New Antifibroblastic Medication in Dermatology: Could Nintedanib Treat Scarring? , 2022, International journal of general medicine.

[4]  A. Tatu,et al.  CREST Syndrome in Systemic Sclerosis Patients – Is Dystrophic Calcinosis a Key Element to a Positive Diagnosis? , 2022, Journal of inflammation research.

[5]  A. Tatu,et al.  Hearing Loss Secondary to Systemic Sclerosis Vasculopathy: Case Study with a Short Review , 2022, Clinical, cosmetic and investigational dermatology.

[6]  V. Wiwanitkit,et al.  Morphea and COVID‐19 mRNA vaccine , 2022, International journal of dermatology.

[7]  T. Krieg,et al.  Pathophysiology of systemic sclerosis (scleroderma) , 2022, The Kaohsiung journal of medical sciences.

[8]  D. Brǎnișteanu,et al.  Mucocutaneous lesions associated with SARS-CoV-2 infection (Review) , 2022, Experimental and therapeutic medicine.

[9]  S. Dash,et al.  Puckered chin sign in systemic sclerosis. , 2022, Journal of the American Academy of Dermatology.

[10]  P. Celepli,et al.  A case of morphea following the COVID‐19 mRNA vaccine: on the basis of viral spike proteins , 2022, International journal of dermatology.

[11]  A. Tatu,et al.  Diagnostic and Management of Undescended Ovary – A Preoperative Dilemma: A Case-Based Systematic Review , 2022, International journal of women's health.

[12]  D. Brǎnișteanu,et al.  Metabolic comorbidities of psoriasis (Review) , 2021, Experimental and therapeutic medicine.

[13]  I. Patoulias,et al.  Balanitis Xerotica Obliterans:an underestimated cause of secondary phimosis. , 2021, Folia medica Cracoviensia.

[14]  D. Iordan,et al.  Age-Related, Sport-Specific Dysfunctions of the Shoulder and Pelvic Girdle in Athletes Table Tennis Players. Observational Study , 2021, Balneo and PRM Research Journal.

[15]  L. Mititelu-Tarțău,et al.  The Analysis of Chitosan-Coated Nanovesicles Containing Erythromycin—Characterization and Biocompatibility in Mice , 2021, Antibiotics.

[16]  L. Rebegea,et al.  Basal cell carcinoma: Comprehensive clinical and histopathological aspects, novel imaging tools and therapeutic approaches (Review) , 2021, Experimental and therapeutic medicine.

[17]  A. Nicolescu MIMOSA TENUIFLORA FOR THE TREATMENT OF DAMAGED SKIN – STUDY ON ITS EFFICACY AND TOLERABILITY IN THE TREATMENT OF IRRITATIVE CONTACT DERMATITIS , 2021, FARMACIA.

[18]  Mihaela Crăescu,et al.  Predictive value of immunological markers in systemic sclerosis , 2021, Experimental and therapeutic medicine.

[19]  M. Miulescu,et al.  An Unusual Case of Meckel Diverticulitis Misdiagnosed as an Infected Urachal Cyst , 2021, Medicina.

[20]  S. Arias-Santiago,et al.  Frontal Fibrosing Alopecia: A Review , 2021, Journal of clinical medicine.

[21]  E. Lazaridou,et al.  Scleredema diabeticorum – A case report , 2021, Journal of family medicine and primary care.

[22]  A. Tatu,et al.  Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its blockade (Review) , 2021, Experimental and therapeutic medicine.

[23]  A. Tatu,et al.  Glucocorticoid-Induced Skin Atrophy: The Old and the New , 2020, Clinical, cosmetic and investigational dermatology.

[24]  I. Gnanasekaran,et al.  Nephrogenic Systemic Fibrosis. , 2020, The American journal of the medical sciences.

[25]  R. Haber,et al.  Scleromyxedema treatment: a systematic review and update , 2020, International journal of dermatology.

[26]  A. Stoian,et al.  Treatment of lipomas and diffuse lipomatosis with NDYAG 1064 NM laser and their impact on the quality of life , 2020 .

[27]  G. Amarilyo,et al.  Systemic Sclerosis Sine Scleroderma With Pulmonary Arterial Hypertension in a 3-Year-Old Girl , 2020, Pediatrics.

[28]  T. Krieg,et al.  Versorgungsrealität der stationären vasoaktiven Therapie mit Prostazyklinderivaten bei Patienten mit akralen Durchblutungsstörungen bei systemischer Sklerose in Deutschland , 2020, Zeitschrift für Rheumatologie.

[29]  B. Breyer,et al.  Pathophysiology, Clinical Manifestations, and Treatment of Lichen Sclerosus: a systematic review. , 2020, Urology.

[30]  C. Preda,et al.  CBCT Evaluation of the Mandibular Bone Quality in Relation to Skeletal Status After Treatment with Strontium Renelate in Diabetic Patients , 2019, Revista de Chimie.

[31]  A. Holland,et al.  Balanitis xerotica obliterans: an update for clinicians , 2019, European Journal of Pediatrics.

[32]  H. Miot,et al.  Case for diagnosis. Sclerodermiform manifestations of porphyria cutanea tarda secondary to hepatitis C* , 2019, Anais brasileiros de dermatologia.

[33]  H. Ihn Eosinophilic fasciitis: From pathophysiology to treatment. , 2019, Allergology international : official journal of the Japanese Society of Allergology.

[34]  C. Antinozzi,et al.  Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components? , 2019, International journal of molecular sciences.

[35]  A. Della Rossa,et al.  One year in review 2019: systemic sclerosis. , 2019, Clinical and experimental rheumatology.

[36]  I. Sharawat,et al.  Multiple sites acquired lipodystrophy in two siblings: a rare adverse effect of intramuscular triamcinolone , 2019, BMJ Case Reports.

[37]  T. Rodríguez-Reyna,et al.  Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast , 2019, BioMed research international.

[38]  A. Tatu,et al.  Statins. A Review on Structural Perspectives, Adverse Reactions and Relations with Non-melanoma Skin Cancer , 2018, Revista de Chimie.

[39]  Saxon D. Smith,et al.  Balanitis xerotica obliterans: a review of diagnosis and management , 2018, International journal of dermatology.

[40]  Male genital lichen sclerosus—a permanent therapeutic challenge , 2018, Journal of the American Academy of Dermatology.

[41]  M. Viggiano,et al.  The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction. , 2018, Clinical and experimental rheumatology.

[42]  L. Benzekri,et al.  Association rare: lichen scléroatrophique extragénital et vitiligo inflammatoire chez un enfant , 2018, The Pan African Medical Journal.

[43]  P. Elsner,et al.  Treatment of Scleroedema Adultorum Buschke: A Systematic Review. , 2018, Acta dermato-venereologica.

[44]  P. Losty,et al.  Does application of topical steroids for lichen sclerosus (balanitis xerotica obliterans) affect the rate of circumcision? A systematic review. , 2018, Journal of pediatric surgery.

[45]  Tammara A. Wood,et al.  Belimumab for the Treatment of Early Diffuse Systemic Sclerosis , 2018, Arthritis & rheumatology.

[46]  Z. Amoura,et al.  [Cancers associated with systemic sclerosis involving anti-RNA polymerase III antibodies]. , 2017, Annales de dermatologie et de venereologie.

[47]  I. Sharawat,et al.  Localized Lipodystrophy following Single Dose Intramuscular Gentamycin Injection , 2017, Indian dermatology online journal.

[48]  A. Tatu,et al.  Pityriasis Folliculorum of the Back Thoracic Area: Pityrosporum, Keratin Plugs, or Demodex Involved? , 2017, Journal of cutaneous medicine and surgery.

[49]  S. Aytekin,et al.  A Rare Syndrome Resembling Scleroderma: Huriez Syndrome , 2017, Skin Appendage Disorders.

[50]  M. Kopeć-Mędrek,et al.  Systemic sclerosis sine scleroderma. , 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[51]  A. Tatu,et al.  Bullous Reactions Associated With COX-2 Inhibitors. , 2017, American journal of therapeutics.

[52]  A. Tatu,et al.  Magistral Prescription With Silver Nitrate and Peru Balsam in Difficult-to-Heal Diabetic Foot Ulcers. , 2017, American journal of therapeutics.

[53]  A. Drosos,et al.  A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease. , 2017, Seminars in arthritis and rheumatism.

[54]  A. Tatu,et al.  CLINICAL, LABORATORY AND THERAPEUTIC PROFILE OF LICHEN PLANUS , 2017 .

[55]  C. Georgescu,et al.  Pharmacological Principles Used in Patient Monitoring with Type 2 Diabetes , 2017 .

[56]  A. Tatu Umbilicated Blue-Black Lesion on the Lateral Thorax , 2017, Journal of cutaneous medicine and surgery.

[57]  R. Monnat,et al.  Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions , 2017, Ageing Research Reviews.

[58]  I. Lazareth,et al.  Paraneoplastic systemic sclerosis: About 3 cases and review of literature. , 2016, Journal des maladies vasculaires.

[59]  F. Strollo,et al.  Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear? , 2016, Diabetes Therapy.

[60]  J. Pope,et al.  A review of the effects of statins in systemic sclerosis. , 2016, Seminars in arthritis and rheumatism.

[61]  V. Vašků,et al.  Paraneoplastic Scleroderma: Are There Any Clues? , 2016, Acta dermatovenerologica Croatica : ADC.

[62]  Y. Asano Recent advances in animal models of systemic sclerosis , 2016, The Journal of dermatology.

[63]  A. Masi,et al.  Progress in the Evolution of Systemic Sclerosis Classification Criteria and Recommendation for Additional Comparative Specificity Studies , 2015, The Journal of Rheumatology.

[64]  B. Kahaleh,et al.  Endothelial dysfunction in systemic sclerosis , 2014, Current opinion in rheumatology.

[65]  S. Hsieh,et al.  Rituximab for refractory digital infarcts and ulcers in systemic sclerosis , 2014, Clinical Rheumatology.

[66]  J. Simms-Cendán,et al.  Clinical recommendation: pediatric lichen sclerosus. , 2014, Journal of pediatric and adolescent gynecology.

[67]  D. Huscher,et al.  Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group , 2014, Annals of the rheumatic diseases.

[68]  Matt Kaeberlein,et al.  mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome , 2013, Science.

[69]  L. Kumar,et al.  Coexistence of scleroderma with multiple myeloma: a rare association , 2013, BMJ Case Reports.

[70]  M. Chatterjee,et al.  Lyme Borreliosis and Skin , 2013, Indian journal of dermatology.

[71]  T. Gambichler,et al.  Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. , 2013, Acta dermato-venereologica.

[72]  Danwei Huangfu,et al.  Human pluripotent stem cells: an emerging model in developmental biology , 2013, Development.

[73]  H. Abujudeh,et al.  Nephrogenic systemic fibrosis. , 2012, AJR. American journal of roentgenology.

[74]  D. Kipling,et al.  p38 MAPK stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes , 2012, Biogerontology.

[75]  G. Stingl,et al.  Successful treatment of poststreptococcal scleredema adultorum Buschke with intravenous immunoglobulins. , 2012, Archives of dermatology.

[76]  A. Caflisch,et al.  Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria. , 2012, Nature chemical biology.

[77]  N. Lawrentschuk,et al.  Penile lichen sclerosus (balanitis xerotica obliterans) , 2011, BJU international.

[78]  J. Lazar,et al.  A Case of Sclerodermatous Graft‐versus‐Host Disease Responsive to Imatinib Therapy , 2011, Pediatric dermatology.

[79]  J. Côté,et al.  Eosinophilic Fasciitis: A Rare Skin Sclerosis , 2010, Pathology research international.

[80]  P. Merkel,et al.  B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis. , 2009, Arthritis and rheumatism.

[81]  J. Weinreb,et al.  Nephrogenic systemic fibrosis. , 2009, Magnetic resonance imaging clinics of North America.

[82]  R. Landewé,et al.  EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) , 2009, Annals of the rheumatic diseases.

[83]  T. Vogt,et al.  Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study. , 2008, European urology.

[84]  A. Herrick,et al.  Raynaud's phenomenon (secondary). , 2008, BMJ clinical evidence.

[85]  M. Panesar,et al.  Nephrogenic Systemic Fibrosis , 2008, American Journal of Nephrology.

[86]  C. Leonetti,et al.  Scleroderma-like disorders. , 2008, Autoimmunity reviews.

[87]  D. Morrell,et al.  Anogenital pruritus: lichen sclerosus in children. , 2007, Pediatric annals.

[88]  S. Baithun,et al.  Human papillomavirus-associated increase in p16INK4A expression in penile lichen sclerosus and squamous cell carcinoma , 2007, The British journal of dermatology.

[89]  N. Hunzelmann,et al.  Differential diagnosis of scleroderma and pseudoscleroderma , 2007, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[90]  F. Roufosse,et al.  SYSTEMIC SCLEROSIS (SCLERODERMA) , 2007, Acta clinica Belgica.

[91]  S. Antoniu Cyclophosphamide for scleroderma interstitial lung disease , 2007, Expert opinion on investigational drugs.

[92]  N. Kluger,et al.  Syndrome de Werner (progeria de l’adulte) , 2007 .

[93]  E. Hachulla,et al.  The complexity of managing systemic sclerosis: screening and diagnosis. , 2006, Rheumatology.

[94]  T. Gambichler,et al.  A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. , 2006, Journal of the American Academy of Dermatology.

[95]  R. Prayson,et al.  Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature. , 2006, Archives of pathology & laboratory medicine.

[96]  Christopher J. Jones,et al.  Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[97]  G. Webster,et al.  Heroic measures may not always be justified in extensive urethral stricture due to lichen sclerosus (balanitis xerotica obliterans). , 2004, Urology.

[98]  J. Bridger,et al.  Aging of Hutchinson–Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis , 2004, Experimental Gerontology.

[99]  W. Ting,et al.  Nephrogenic fibrosing dermopathy with systemic involvement. , 2003, Archives of dermatology.

[100]  C. Mok,et al.  Scleroderma renal crisis sine scleroderma during pregnancy , 2003, Scandinavian journal of rheumatology.

[101]  S. Neill,et al.  Guidelines for the management of lichen sclerosus , 2002, The British journal of dermatology.

[102]  S. Buechner Common skin disorders of the penis , 2002, BJU international.

[103]  E. Kilbourne,et al.  The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge. , 2002, Environmental health perspectives.

[104]  Y. Suga,et al.  Two Japanese cases of localized involutional lipoatrophy , 2002, International journal of dermatology.

[105]  J. Nava,et al.  Scleroderma Renal Crisis Sine Scleroderma , 2001, Nephron.

[106]  R. Romiti,et al.  Progeria Infantum (Hutchinson–Gilford Syndrome) Associated with Scleroderma‐Like Lesions and Acro‐Osteolysis: A Case Report and Brief Review of the Literature , 2000, Pediatric dermatology.

[107]  A. García‐Díez,et al.  Lichen sclerosus et atrophicus in sclerodermatous chronic graft‐versus‐host disease , 1999, International journal of dermatology.

[108]  F. Wojnarowska,et al.  Lichen sclerosus , 1999, The Lancet.

[109]  U. Haustein,et al.  Drug-induced scleroderma and sclerodermiform conditions. , 1998, Clinics in dermatology.

[110]  S. Jablonska,et al.  Scleroderma-like disorders. , 1998, Seminars in cutaneous medicine and surgery.

[111]  E. Bröcker,et al.  The scleroatrophic syndrome of Huriez: a cancer‐prone genodermatosis , 1996, The British journal of dermatology.

[112]  G. Saed,et al.  Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. , 1995, Journal of the American Academy of Dermatology.

[113]  Richard W. Martin,et al.  Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. , 1995, The Journal of rheumatology.

[114]  R. Madhok,et al.  Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study. , 1995, Annals of the rheumatic diseases.

[115]  K. Cann,et al.  Acrodermatitis chronica atrophicans: a case report and review of the literature , 1994, The British journal of dermatology.

[116]  S. Buechner,et al.  Atrophoderma of Pasini and Pierini. Clinical and histopathologic findings and antibodies to Borrelia burgdorferi in thirty-four patients. , 1994, Journal of the American Academy of Dermatology.

[117]  R. Takaki,et al.  A case of primary biliary cirrhosis associated with Hashimoto's thyroiditis, scleroderma and Sjögren's syndrome. , 1992, Internal medicine.

[118]  I. Téllez,et al.  Extracardiac vascular and neural lesions in the toxic oil syndrome. , 1991, Journal of the American College of Cardiology.

[119]  M. Tsai,et al.  Studies of phenylketonurics with dermatitis. , 1981, Journal of the American Academy of Dermatology.

[120]  K. Hashimoto,et al.  Acrosclerosis Associated with Vibration: an Electron Microscopic Study , 1980, Journal of cutaneous pathology.

[121]  A. Masi Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[122]  B. Kwiatkowska-Patzer,et al.  [Pseudoscleroderma in a 16-month-old boy with phenylketonuria]. , 1975, Wiadomosci lekarskie.

[123]  M. Jänner,et al.  [Follicular mucinosis and large area, partly lichenoid, partly sclerodermiform generalized paramyloidosis as a cutaneous paraneoplastic syndrome in myeloma (IgD and light chain plasmacytoma)]. , 1974, Zeitschrift fur Hautkrankheiten.

[124]  R. Koch,et al.  Phenylketonuria and scleroderma. , 1968, The Journal of pediatrics.

[125]  Z. Št̕áva,et al.  [Skin manifestations in phenylketonuria. A case with sclerodermiform manifestations]. , 1966, Ceskoslovenska dermatologie.

[126]  N. Longo,et al.  Phenylketonuria , 1964, Neurology.

[127]  L. Czirják,et al.  Sclerodermalike syndromes: Great imitators. , 2020, Clinics in dermatology.

[128]  A. Tatu,et al.  MULTIPLE AUTOIMMUNE SYNDROME TYPE 3- THYROIDITIS,VITILIGO AND ALOPECIA AREATA. , 2017, Acta endocrinologica.

[129]  A. Herrick,et al.  Digital ulcers in systemic sclerosis , 2017, Rheumatology.

[130]  C. Denton Advances in pathogenesis and treatment of systemic sclerosis. , 2016, Clinical medicine.

[131]  L. Hummers,et al.  Scleroderma Mimickers , 2016, Current Treatment Options in Rheumatology.

[132]  J. D. da Silva,et al.  Paraneoplastic sclerodermiform syndrome--case report. , 2014, Acta reumatologica portuguesa.

[133]  K. Becker Lichen sclerosus in boys. , 2011, Deutsches Arzteblatt international.

[134]  A. Cuvelier,et al.  [Paraneoplastic sclerodermiform syndrome]. , 2010, Revue des maladies respiratoires.

[135]  M. Seyger,et al.  Efficacy of Topical Tacrolimus 0.1% in Active Plaque Morphea , 2009, American journal of clinical dermatology.

[136]  P. Bale,et al.  Balanitis xerotica obliterans in children. , 1987, Pediatric pathology.

[137]  F. Cambazard,et al.  [Pseudoscleroderma and sclerodermiform states]. , 1984, Annales de medecine interne.

[138]  Z. Kraus Acrodermatitis chronica atrophicans. , 1970, Sbornik vedeckych praci Lekarske fakulty Karlovy university v Hradci Kralove.